Pulmuone Future Growth

Future criteria checks 3/6

Pulmuone is forecast to grow earnings and revenue by 51.4% and 5.2% per annum respectively. EPS is expected to grow by 51.1% per annum. Return on equity is forecast to be 17.3% in 3 years.

Key information

51.4%

Earnings growth rate

51.1%

EPS growth rate

Food earnings growth	16.3%
Revenue growth rate	5.2%
Future return on equity	17.3%
Analyst coverage	Low
Last updated	28 Jun 2024

Recent future growth updates

Recent updates

Pulmuone's (KRX:017810) Returns Have Hit A Wall

Jun 12

Pulmuone Corporate (KRX:017810) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

May 24

Market Participants Recognise Pulmuone Corporate's (KRX:017810) Revenues Pushing Shares 31% Higher

May 24

We Think Pulmuone's (KRX:017810) Profit Is Only A Baseline For What They Can Achieve

Mar 27

Is Now An Opportune Moment To Examine Pulmuone Co., Ltd. (KRX:017810)?

Apr 13

There Are Reasons To Feel Uneasy About Pulmuone's (KRX:017810) Returns On Capital

Mar 26

Pulmuone Co., Ltd. (KRX:017810) Is Yielding 0.6% - But Is It A Buy?

Mar 08

Here's Why Pulmuone (KRX:017810) Has A Meaningful Debt Burden

Feb 18

Does Pulmuone's (KRX:017810) Share Price Gain of 57% Match Its Business Performance?

Jan 31

Based On Its ROE, Is Pulmuone Co., Ltd. (KRX:017810) A High Quality Stock?

Jan 13

When Should You Buy Pulmuone Co., Ltd. (KRX:017810)?

Dec 26

Key Things To Watch Out For If You Are After Pulmuone Co., Ltd.'s (KRX:017810) 0.6% Dividend

Dec 08

These 4 Measures Indicate That Pulmuone (KRX:017810) Is Using Debt Extensively

Nov 20

Earnings and Revenue Growth Forecasts

KOSE:A017810 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	3,500,400	77,200	N/A	208,000	1
12/31/2025	3,309,600	64,100	N/A	203,900	1
12/31/2024	3,142,750	43,950	25,300	188,050	2
3/31/2024	3,032,722	8,857	39,242	156,538	N/A
12/31/2023	2,993,468	9,365	66,157	193,580	N/A
9/30/2023	2,958,921	-36,229	48,350	172,460	N/A
6/30/2023	2,967,237	-32,783	27,389	161,103	N/A
3/31/2023	2,917,752	-29,683	-29,283	116,591	N/A
12/31/2022	2,838,304	-29,957	-54,529	92,256	N/A
9/30/2022	2,752,559	-1,547	-96,461	102,996	N/A
6/30/2022	2,659,691	-786	-97,638	104,899	N/A
3/31/2022	2,588,871	-3,820	-114,780	105,871	N/A
12/31/2021	2,518,896	5,326	-104,573	118,483	N/A
9/30/2021	2,457,293	12,577	-63,175	120,492	N/A
6/30/2021	2,399,108	12,989	-78,237	101,972	N/A
3/31/2021	2,329,175	17,542	-26,907	119,900	N/A
12/31/2020	2,311,200	14,880	-45,707	103,961	N/A
9/30/2020	2,339,353	15,663	-61,553	84,400	N/A
6/30/2020	2,362,839	13,047	-33,498	108,378	N/A
3/31/2020	2,394,780	15,121	-59,803	86,106	N/A
12/31/2019	2,381,451	2,092	-41,900	85,410	N/A
9/30/2019	2,341,499	12,708	-8,649	107,434	N/A
6/30/2019	2,300,882	15,531	-17,709	74,623	N/A
3/31/2019	2,276,085	15,987	-14,116	77,653	N/A
12/31/2018	2,271,973	20,448	-37,886	59,291	N/A
9/30/2018	2,257,209	24,953	-47,932	42,099	N/A
6/30/2018	2,244,986	29,473	-62,242	53,537	N/A
3/31/2018	2,222,750	35,628	-67,181	45,481	N/A
12/31/2017	2,195,658	38,506	N/A	62,648	N/A
9/30/2017	2,182,182	42,149	N/A	59,331	N/A
6/30/2017	2,134,206	36,862	N/A	47,607	N/A
3/31/2017	2,089,078	20,413	N/A	60,222	N/A
12/31/2016	2,030,673	18,595	N/A	57,937	N/A
9/30/2016	1,963,638	20,184	N/A	54,603	N/A
6/30/2016	1,917,451	12,666	N/A	66,996	N/A
3/31/2016	1,874,813	19,773	N/A	38,453	N/A
12/31/2015	1,846,488	20,319	N/A	106,415	N/A
9/30/2015	1,822,004	58,819	N/A	121,686	N/A
6/30/2015	1,789,627	60,187	N/A	118,992	N/A
3/31/2015	1,743,290	57,841	N/A	144,260	N/A
12/31/2014	1,678,094	55,023	N/A	82,174	N/A
9/30/2014	1,615,684	-5,251	N/A	78,694	N/A
6/30/2014	1,565,074	-3,726	N/A	100,735	N/A
3/31/2014	1,538,641	-6,555	N/A	99,135	N/A
12/31/2013	1,521,708	-6,299	N/A	111,377	N/A
9/30/2013	1,501,571	6,394	N/A	99,935	N/A
6/30/2013	1,490,743	9,633	N/A	82,627	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A017810's forecast earnings growth (51.4% per year) is above the savings rate (2.5%).

Earnings vs Market: A017810's earnings (51.4% per year) are forecast to grow faster than the KR market (29.2% per year).

High Growth Earnings: A017810's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: A017810's revenue (5.2% per year) is forecast to grow slower than the KR market (10.6% per year).

High Growth Revenue: A017810's revenue (5.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A017810's Return on Equity is forecast to be low in 3 years time (17.3%).

Pulmuone Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Price target decreased to ₩19,000

Consensus forecasts updated

Consensus forecasts updated

Consensus forecasts updated

Recent updates

New minor risk - Share price stability

Pulmuone's (KRX:017810) Returns Have Hit A Wall

Investor sentiment improves as stock rises 16%

Pulmuone Corporate (KRX:017810) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

Market Participants Recognise Pulmuone Corporate's (KRX:017810) Revenues Pushing Shares 31% Higher

Investor sentiment improves as stock rises 16%

High number of new directors

We Think Pulmuone's (KRX:017810) Profit Is Only A Baseline For What They Can Achieve

Upcoming dividend of ₩102 per share at 1.0% yield

New major risk - Revenue and earnings growth

Full year 2022 earnings released: ₩724 loss per share (vs ₩145 profit in FY 2021)

Upcoming dividend of ₩102 per share

Third quarter 2022 earnings released: EPS: ₩298 (vs ₩293 in 3Q 2021)

Insufficient new directors

Price target decreased to ₩19,000

Insufficient new directors

Insufficient new directors

Upcoming dividend of ₩102 per share

Consensus forecasts updated

Consensus forecasts updated

Consensus forecasts updated

Investor sentiment improved over the past week

Is Now An Opportune Moment To Examine Pulmuone Co., Ltd. (KRX:017810)?

There Are Reasons To Feel Uneasy About Pulmuone's (KRX:017810) Returns On Capital

Full year 2020 earnings released: EPS ₩399 (vs ₩56.00 in FY 2019)

Pulmuone Co., Ltd. (KRX:017810) Is Yielding 0.6% - But Is It A Buy?

Pulmuone Co., Ltd., Annual General Meeting, Mar 25, 2021

Here's Why Pulmuone (KRX:017810) Has A Meaningful Debt Burden

Does Pulmuone's (KRX:017810) Share Price Gain of 57% Match Its Business Performance?

Based On Its ROE, Is Pulmuone Co., Ltd. (KRX:017810) A High Quality Stock?

New 90-day high: ₩18,650

When Should You Buy Pulmuone Co., Ltd. (KRX:017810)?

Upcoming Dividend of ₩102 Per Share

Key Things To Watch Out For If You Are After Pulmuone Co., Ltd.'s (KRX:017810) 0.6% Dividend

These 4 Measures Indicate That Pulmuone (KRX:017810) Is Using Debt Extensively

Pulmuone Co., Ltd. (KOSE:A017810) agreed to acquire 51% stake in Pulmuone Waters Co., Ltd. from Nestlé S.A. (SWX:NESN) for KRW 36 billion.

New 90-day low: ₩15,600

New 90-day low: ₩16,400

New 90-day high - ₩21,200

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies